» Articles » PMID: 32174118

Identifying Significant Metabolic Pathways Using Multi-Block Partial Least-Squares Analysis

Overview
Journal J Proteome Res
Specialty Biochemistry
Date 2020 Mar 17
PMID 32174118
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

In metabolomics, identification of metabolic pathways altered by disease, genetics, or environmental perturbations is crucial to uncover the underlying biological mechanisms. A number of pathway analysis methods are currently available, which are generally based on equal-probability, topological-centrality, or model-separability methods. In brief, prior identification of significant metabolites is needed for the first two types of methods, while each pathway is modeled separately in the model-separability-based methods. In these methods, interactions between metabolic pathways are not taken into consideration. The current study aims to develop a novel metabolic pathway identification method based on multi-block partial least squares (MB-PLS) analysis by including all pathways into a global model to facilitate biological interpretation. The detected metabolites are first assigned to pathway blocks based on their roles in metabolism as defined by the KEGG pathway database. The metabolite intensity or concentration data matrix is then reconstructed as data blocks according to the metabolite subsets. Then, a MB-PLS model is built on these data blocks. A new metric, named the pathway importance in projection (PIP), is proposed for evaluation of the significance of each metabolic pathway for group separation. A simulated dataset was generated by imposing artificial perturbation on four pre-defined pathways of the healthy control group of a colorectal cancer study. Performance of the proposed method was evaluated and compared with seven other commonly used methods using both an actual metabolomics dataset and the simulated dataset. For the real metabolomics dataset, most of the significant pathways identified by the proposed method were found to be consistent with the published literature. For the simulated dataset, the significant pathways identified by the proposed method are highly consistent with the pre-defined pathways. The experimental results demonstrate that the proposed method is effective for identification of significant metabolic pathways, which may facilitate biological interpretation of metabolomics data.

Citing Articles

Current approaches and outstanding challenges of functional annotation of metabolites: a comprehensive review.

Nguyen Q, Nguyen H, Oh E, Nguyen T Brief Bioinform. 2024; 25(6).

PMID: 39397425 PMC: 11471905. DOI: 10.1093/bib/bbae498.


Metabolomic analysis of hydroxycinnamic acid inhibition on Saccharomyces cerevisiae.

Ge X, Chen J, Gu J, Yi W, Xu S, Tan L Appl Microbiol Biotechnol. 2024; 108(1):165.

PMID: 38252275 PMC: 10803543. DOI: 10.1007/s00253-023-12830-8.


Comparison of freeze-thaw and sonication cycle-based methods for extracting AMR-associated metabolites from .

Singh R, Thakur L, Kumar A, Singh S, Kumar S, Kumar M Front Microbiol. 2023; 14:1152162.

PMID: 37180233 PMC: 10174324. DOI: 10.3389/fmicb.2023.1152162.


Exploration of Blood Metabolite Signatures of Colorectal Cancer and Polyposis through Integrated Statistical and Network Analysis.

Di Cesare F, Vignoli A, Luchinat C, Tenori L, Saccenti E Metabolites. 2023; 13(2).

PMID: 36837915 PMC: 9965766. DOI: 10.3390/metabo13020296.


Metabolic flux between organs measured by arteriovenous metabolite gradients.

Bae H, Lam K, Jang C Exp Mol Med. 2022; 54(9):1354-1366.

PMID: 36075951 PMC: 9534916. DOI: 10.1038/s12276-022-00803-2.

References
1.
Rosato A, Tenori L, Cascante M, De Atauri Carulla P, Martins Dos Santos V, Saccenti E . From correlation to causation: analysis of metabolomics data using systems biology approaches. Metabolomics. 2018; 14(4):37. PMC: 5829120. DOI: 10.1007/s11306-018-1335-y. View

2.
Deng L, Gu H, Zhu J, Gowda G, Djukovic D, Chiorean E . Combining NMR and LC/MS Using Backward Variable Elimination: Metabolomics Analysis of Colorectal Cancer, Polyps, and Healthy Controls. Anal Chem. 2016; 88(16):7975-83. PMC: 5450811. DOI: 10.1021/acs.analchem.6b00885. View

3.
Al-Akwaa F, Yunits B, Huang S, Alhajaji H, Garmire L . Lilikoi: an R package for personalized pathway-based classification modeling using metabolomics data. Gigascience. 2018; 7(12). PMC: 6290884. DOI: 10.1093/gigascience/giy136. View

4.
Jahani M, Noroznezhad F, Mansouri K . Arginine: Challenges and opportunities of this two-faced molecule in cancer therapy. Biomed Pharmacother. 2018; 102:594-601. DOI: 10.1016/j.biopha.2018.02.109. View

5.
Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y . Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J Proteome Res. 2009; 8(10):4844-50. DOI: 10.1021/pr9004162. View